NCT07020559View on ClinicalTrials.gov

Allogeneic vs Autologous PRP for Diabetic Wounds in Renal Dysfunction: a Randomized Controlled Trial

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

April 30, 2026

Primary Completion Date

December 31, 2027

Study Completion Date

May 31, 2028

Conditions
Diabetic WoundsPlatelet Rich PlasmaAllogeneic Blood TransfusionsRenal Dysfunction
Interventions
DRUG

allogeneic platelet plasma

Al-PRP derived from healthy blood donors

DRUG

autologous platelet plasma

Autologous platelet-rich plasma from the patient themselves

Trial Locations (1)

100191

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER